
|Articles|June 1, 2002
Supplements and Featured Publications
- Protection Across the Cardiovascular Continuum: What Can Be Done for Patients at Risk?
- Volume 8
- Issue 9 Suppl
Beta Blockers as Cardioprotective Agents: Part I -- Insights into Mechanisms of Action
Author(s)William H. Frishman, MD
Advertisement
Articles in this issue
over 23 years ago
Introductionover 23 years ago
Cardioprotection: What Is It? Who Needs It?over 23 years ago
Statins as Cardioprotective Agentsover 23 years ago
ACE Inhibitors as Cardioprotective Agentsover 23 years ago
Role of Antiplatelet Agents in Cardioprotectionover 23 years ago
Call to ActionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
2
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
3
Making the Genetic Models Match the Ancestry of Patient Populations
4
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
5














































